Answers are grounded in this paper and cite their sources.
Demonstrates immune modulation through TGFβ reduction in regulatory T-cells, suggesting new therapeutic avenues.
populations of Tregs from mice, 1 was able to block a glioma-conditioned medium-induced increase in TGFβ production. This comprehensive characterization of a small-molecule NRP1 antagonist provides the basis for future in vivo studies.
No takes yet. Share an insight, caveat, or question.
Powell et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: